How to reduce the risk of coronary artery disease

References

• Carleton RA, Dwyer J, Finberg L, et al. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: a statement from the National Cholesterol Education Program, National Heart, Lung, and Blood Institute, National Institutes of Health. Circulation 1991: 83(6): 2154–232
   PubMed Web of Science ®Google Scholar
• Castelli W, Leaf A. Identification and assessment of cardiac risk: an overview. Cardiol Clin 1985: 3(2): 171–8
   Google Scholar
• Cohen MV, Byrne MJ, Levine B, et al. Low rate of treatment of hypercholesterolemia by cardiologists in patients with suspected and proven coronary artery disease. Circulation 1991: 83(4): 1294–304
   PubMed Web of Science ®Google Scholar
• Castelli WP, Wilson FW, Levy D, et al. Cardiovascular risk factors in the elderly. Am J Cardiol 1989: 63(16): 12–9H
   PubMed Web of Science ®Google Scholar
• Lipid Research Clinics Program. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984: 251 (3): 365–74
   PubMed Web of Science ®Google Scholar
• The Expert Panel. Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988: 148(1): 36–69
   PubMedGoogle Scholar
• Gordon DJ, Probstfield JL, Rubenstein C, et al. Coronary risk factors and exercise test performance in asymptomatic hypercholesterolemic men: application of proportional hazards analysis. Am J Epidemiol 1984: 120(2): 210–24
   PubMed Web of Science ®Google Scholar
• Gofman JW, Young W, Tandy R. Ischemic heart disease, atherosclerosis, and longevity. Circulation 1966: 34(4): 679–97
   PubMed Web of Science ®Google Scholar
• Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 1989: 79(1): 8–15
   PubMed Web of Science ®Google Scholar
• Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA 1986: 256(20): 2835–8
   PubMed Web of Science ®Google Scholar
• Fievet C, Nuttens MC, Ducimetiere P, et al. Relation of arteriographically defined coronary artery disease to serum lipoprotein particles mapped with monoclonal antibodies. Circulation 1991: 84(1): 153–9
   PubMed Web of Science ®Google Scholar
• Gotto AM Jr, Farmer JA. Risk factors for coronary artery disease. In: Braunwald E, ed. Heart disease: a textbook of cardiovascular medicine. 3d ed, vol 2. Philadelphia: WB Saunders, 1988: 1153–90
   Google Scholar
• Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension: the Framingham study. Circulation 1980: 61(6): 1179–82
   PubMed Web of Science ®Google Scholar
• Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989: 149(7): 1514–20
   PubMedGoogle Scholar
• Ibsen H, Hilden T. New views on the relationship between coronary heart disease and hypertension. J Intern Med 1990: 227(2): 77–9
   PubMed Web of Science ®Google Scholar
• Kreger BE. Coronary risk factors: insights from Framingham. Clin Cardiol 1991: 14(Suppl III):III3–12
   Google Scholar
• Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989: 110(2): 101–7
   PubMed Web of Science ®Google Scholar
• Dzau V, Braunwald E. Resolved and unresolved issues in the prevention and treatment of coronary artery disease: a workshop consensus statement. Am Heart J 1991: 121(4 Pt 1): 1244–63
   PubMed Web of Science ®Google Scholar
• The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984: 144(5): 1045–57
   PubMedGoogle Scholar
• Fielding JE. Smoking: health effects and control. 1. N Engl J Med 1985: 313(8): 491–8
   PubMed Web of Science ®Google Scholar
• Brischetto CS, Connor WE, Connor SL, et al. Plasma lipid and lipoprotein profiles of cigarette smokers from randomly selected families: enhancement of hyperlipidemia and depression of high-density lipoprotein. Am J Cardiol 1983: 52: 675–80
   PubMed Web of Science ®Google Scholar
• Kaufman DW, Helmrich SP, Rosenberg L, et al. Nicotine and carbon monoxide content of cigarette smoke and the risk of myocardial infarction in young men. N Engl J Med 1983: 308(8): 409–13
   PubMed Web of Science ®Google Scholar
• Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 1983: 67(5): 968–7724.
   PubMed Web of Science ®Google Scholar
• Donahue RP, Abbott RD, Bloom E, et al. Central obesity and coronary heart disease in men. Lancet 1987: 1(8537): 821–4
   PubMed Web of Science ®Google Scholar
• Kannel WB. Lipids, diabetes, and coronary heart disease: insights from the Framingham study. Am Heart J 1985: 110(5): 1100–6
   PubMed Web of Science ®Google Scholar
• Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile: a statement for health professionals. Circulation 1991: 83(1): 356–62
   PubMed Web of Science ®Google Scholar
• Fuller JH, Shipley MJ, Rose G, et al. Coronary-heart-disease risk and impaired glucose tolerance: the Whitehall study. Lancet 1980: 1 (8183): 1373–6
   PubMed Web of Science ®Google Scholar
• Colwell JA, Winocour PD, Lopes-Virella M, et al. New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 1983: 75(5B): 67–80
   PubMed Web of Science ®Google Scholar
• Gordon NF, Scott CB. The role of exercise in the primary and secondary prevention of coronary artery disease. Clin Sports Med 1991: 10(1): 87–103
   PubMed Web of Science ®Google Scholar
• Butler RM, Goldberg L. Exercise and prevention of coronary heart disease. Prim Care 1989: 16(1): 99–114
   PubMed Web of Science ®Google Scholar
• Bennett P, Carroll D. Stress management approaches to the prevention of coronary heart disease. Br J Clin Psychol 1990: 29(Pt 1): 1–12
   PubMedGoogle Scholar
• Thornton J, Symes C, Heaton K. Moderate alcohol intake reduces bile cholesterol saturation and raises HDL cholesterol. Lancet 1983: 2(8354): 819–22
   PubMed Web of Science ®Google Scholar
• Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991: 338(8765): 464–8
   PubMed Web of Science ®Google Scholar